ProViu transforms conventional ultrasound into a powerful imaging platform enabled by super-resolution ultrasound, a novel microvascular imaging modality with up to 20x increased resolution, enabling earlier, faster and more accurate diagnosis.

A Novel Ultrasound
Imaging Modality
for Prostate
Cancer Diagnosis

Super-Resolution Microvascular Imaging

ProViu generates detailed maps of prostate microvasculature by tracking microbubble contrast agents, revealing previously unseen vascular patterns associated with cancer that are invisible to conventional ultrasound.

MRI-Level Insight at Point of Care

Next Generation of Point-of-Care Diagnostics: Our imaging platform brings mpMRI-imaging performance to Urology departments - without new hardware, new infrastructure, or new workflows.

AI-Driven Diagnostic Confidence

Advanced machine learning algorithms detect vascular signatures, and support consistent, decision–ready outputs for clinicians during patient visit.

Who We Are

Less Grey Imaging is a Med Tech company developing next-generation ultrasound-based imaging for prostate cancer diagnosis.

Founded in 2023 as a spinout from Heriot-Watt University, Edinburgh, we combine ultrasound physics, applied mathematics, and AI to deliver clinically actionable imaging at the point of care.

About Us

Pioneering a new standard in prostate cancer diagnosis

Less Grey Imaging is redefining how prostate cancer is detected and diagnosed. Our proprietary platform, ProViu, transforms conventional ultrasound into high-resolution microvascular imaging — enabling clinicians to identify cancer earlier and make confident decisions during the patient visit.

Current diagnostic pathways rely heavily on multiparametric MRI, which is costly, capacity-limited, and can miss up to 28% of clinically significant cancers. In addition, over 35% of patients with a positive MRI result do not have prostate cancer, leading to unnecessary biopsy procedures.

ProViu addresses this gap by delivering MRI-comparable imaging performance using standard ultrasound systems — without the infrastructure, delays, or constraints of traditional imaging workflows.

AI-Powered Image Enhancement

ProViu tracks microbubble contrast agents using standard ultrasound systems to generate super-resolution images of prostate microvasculature. By overcoming the acoustic diffraction limit, it reveals vascular patterns associated with cancer that are invisible to conventional imaging.

Structural Detail Recovery

Our technology reconstructs microvascular structures at up to 20× higher resolution than standard ultrasound, restoring critical diagnostic detail and enabling earlier and more accurate lesion detection.

Automated Quality Assessment

Built-in quality assessment algorithms continuously evaluate image clarity, contrast, and diagnostic reliability — ensuring consistent, high-quality outputs across operators and clinical settings.